Adar Poonawalla, Head of Indian biotech company Serum Institute of India, in an event on 1 September, announced the scientific completion of the company's Human Papillomavirus (HPV) inoculation against cervical cancer.
SII's HPV vaccine is all set to be India's first homegrown HPV vaccine, and is likely to be launched in a few months, he added.
Scientific completion means that the Research & Development stage of the vaccine is complete. The next step would be production of the vaccine, so they can be made available to the public.
Read Latest News and Breaking News at The Quint, browse for more from fit
Published:


